Rising Demand for Pain Management Devices: A Global Market Overview
The pain management devices market has grown significantly in recent
years. This growth is due to increasing awareness of the various types
of pain management devices available and their effectiveness in treating
various types of pain. In addition, the increasing availability of
these devices has made them more accessible to a wider range of people.
According to a report the global pain management devices market
was valued $2.2 billion in 2021 and is poised to reach $3.3 billion by
2026, growing at a CAGR of 8.6% from 2021 to 2026. This growth is being
driven by increasing prevalence of chronic pain, the introduction of
advanced pain management devices, and the rising demand for minimally
invasive and non-invasive treatments.
The global pain management devices market is segmented on the basis of product, application, end user, and geography.
The
pain management devices market consists of a variety of products,
including electrical stimulation devices, ablation devices, implantable
pumps, and neuromodulation devices. Electrical stimulation devices are
used to reduce nerve pain through electrical stimulation. Ablation
devices are used to reduce pain through the destruction of nerve
endings. Implantable pumps deliver anesthetic medications directly to
the site of pain. Neuromodulation devices provide electrical stimulation
to the brain and spinal cord to relieve pain.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=91418163
In
terms of effectiveness, electrical stimulation devices are the most
commonly used pain management devices. Studies have found that
electrical stimulation devices are effective in treating a variety of
pain conditions, including back pain, neck pain, and joint pain.
Ablation devices are also effective in reducing pain, but they are most
commonly used to treat chronic pain. Implantable pumps and
neuromodulation devices are effective in treating more severe forms of
pain, such as cancer-related pain and neuropathic pain.
The
global pain management devices market is expected to continue to grow in
the coming years due to the increasing prevalence of chronic pain, the
introduction of advanced pain management devices, and the rising demand
for minimally invasive and non-invasive treatments. As more people
become aware of the various types of pain management devices available,
the demand for these devices is expected to grow.
Pain Management Devices Market Key players
Medtronic
is the leading player in the pain management devices market. The
company, as part of its marketing and sales strategy, focuses on rapid
and cost-effective product delivery to its global customers.
Additionally, the company maintains strong relationships with physicians
and providers to gain a detailed understanding of their requirements.
The company has gained a major share in the neuromodulation market
because of its diversified product portfolio, widespread geographical
presence, focus on inorganic growth strategies, strong focus on R&D,
and aggressive marketing and sales strategies.
Boston Scientific
is one of the key players in the pain management devices market.
Through its Rhythm Management segment, the company provides
neuromodulation products, such as rechargeable spinal cord stimulators
and microstimulators for managing neuropathic pain. Moreover, Boston
Scientific has a strong geographic presence in more than 40 countries
globally. The company markets and distributes its products to ~13,000
hospitals, clinics, outpatient facilities, and medical offices in over
100 countries worldwide.
In conclusion, the global pain
management devices market is expected to continue to grow in the coming
years due to the increasing prevalence of chronic pain and the
introduction of advanced pain management devices. As more people become
aware of the various types of pain management devices available and
their effectiveness in treating different forms of pain, the demand for
these devices is expected to continue to grow.
Pain Management Devices Market Regional Analysis
The
global pain management devices market is estimated to be dominated by
North America, owing to the rising prevalence of chronic pain,
increasing number of geriatric population, and the presence of major
market players in the region. According to the National Institute of
Health (NIH), in 2016, approximately 25.3 million people in the U.S.
suffer from chronic pain, and an estimated 116 million people suffer
from chronic pain in 2016. Moreover, the rise in R&D activities for
the development of innovative pain management devices, and favorable
reimbursement policies are expected to fuel the growth of the market in
the region.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=91418163
Europe
is expected to hold the second largest share of the global pain
management devices market. The growing prevalence of chronic pain in the
region, rising healthcare expenditure, and the presence of advanced
healthcare infrastructure are the major factors driving the growth of
the market. According to the World Health Organization (WHO), in 2017,
around 50 million people in the EU were affected by chronic pain.
Asia Pacific is estimated to be the fastest growing region in the global pain management devices market,
owing to the growing geriatric population, rising prevalence of chronic
pain, increasing healthcare expenditure, and rising awareness about the
pain management devices.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
Comments
Post a Comment